These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7243776)

  • 21. Gabexate mesilate and heparin responsiveness in coronary patients.
    Ranucci M
    Med Sci Monit; 2004 Mar; 10(3):PI40-3. PubMed ID: 14976449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipid concentrations correlate with the progression of chronic renal failure.
    Yang WQ; Song NG; Ying SS; Liang HQ; Zhang YJ; Wei MJ; Wu KF
    Clin Lab Sci; 1999; 12(2):104-8. PubMed ID: 10387487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
    Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroid hormone is not an inhibitor of lipoprotein lipase activity.
    Arnadottir M; Nilsson-Ehle P
    Nephrol Dial Transplant; 1994; 9(11):1586-9. PubMed ID: 7870347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antioxidant capacity on blood lipid metabolism and lipoprotein lipase activity of rats fed a high-fat diet.
    Yang R; Le G; Li A; Zheng J; Shi Y
    Nutrition; 2006; 22(11-12):1185-91. PubMed ID: 17095404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis].
    Miler M; Zamojska S; Fijałkowski P; Lobos M; Paradowski MT
    Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prescribing a high protein diet and increasing the dose of dialysis on nutrition in stable chronic haemodialysis patients: a randomized, controlled trial.
    Kloppenburg WD; Stegeman CA; Hovinga TK; Vastenburg G; Vos P; de Jong PE; Huisman RM
    Nephrol Dial Transplant; 2004 May; 19(5):1212-23. PubMed ID: 14993506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of various heparin preparations on lipoproteins in hemodialysis patients: a multicentre study.
    Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Meisl T; Pinter G; Dieplinger H
    Thromb Haemost; 1995 Oct; 74(4):1025-8. PubMed ID: 8560405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipid profile in maintenance haemodialysis].
    Jamoussi K; Ayedi F; Abida N; Kamoun K; Féki H; Chaabouni MN; Hammouda F; Bahloul I; Bellaj A; Hachicha J; Ellouz F
    Pathol Biol (Paris); 2005 May; 53(4):217-20. PubMed ID: 15850955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Postheparinic lipolytic activity in diabetes].
    Plamieniak L
    Pol Tyg Lek; 1974 Jul; 29(28):1197-200. PubMed ID: 4846887
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of eosinophilia on the heterogeneity of the anticoagulant response to heparin in haemodialysis patients.
    Santoro A; Zucchelli P; Trombetti E; Degli Esposti E; Sturani A; Zuccalà A; Chiarini C; Casadei-Maldini M; Mazzuca A
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():143-9. PubMed ID: 3991493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of heparin on blood lipolytic and coagulation activity in patients with hypertensive disease].
    Oleĭnik NI
    Klin Med (Mosk); 1969 Jul; 47(7):75-9. PubMed ID: 5385094
    [No Abstract]   [Full Text] [Related]  

  • 35. [Post-heparin plasmatic lipolytic activity (PHLA) and related pre-heparin plasmatic inhibitor in liver diseases].
    Donnini L
    Riv Crit Clin Med; 1967 Oct; 67(5):408-15. PubMed ID: 5604191
    [No Abstract]   [Full Text] [Related]  

  • 36. [Characteristics of the inhibitory action of the blood serum of atherosclerotic patients on the lipolytic activity of the aortic wall].
    Lempert BL; Aleksandrova EA; Karlitskiĭ NM
    Biull Eksp Biol Med; 1971 Nov; 72(11):27-8. PubMed ID: 5131029
    [No Abstract]   [Full Text] [Related]  

  • 37. [Methylester of palmitic acid as a substrate for the post-heparin lipolytic activity in normal persons and atherosclerotics].
    Skorepa J; Fucík M; Mares P; Novák S
    Sb Lek; 1967; 69(11):316-21. PubMed ID: 6076969
    [No Abstract]   [Full Text] [Related]  

  • 38. Fat clearance before and after heparin in chronic renal failure--haemodialysis reduces post-heparin fractional clearance rates of intralipid.
    Chan MK; Varghese Z; Persaud JW; Baillod RA; Moorhead JF
    Clin Chim Acta; 1980 Nov; 108(1):95-101. PubMed ID: 7449141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Action of heparin on blood lipids and on the rate of glucose assimilation in the normal subject].
    Balasse E
    Rev Fr Etud Clin Biol; 1966 Jan; 11(1):79-82. PubMed ID: 5907278
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lipid metabolism and aging. II. Effect of heparin on the free fatty acid level in relation to age atherosclerosis].
    Stuchlíková E; Hrusková J; Hrůza Z; Jelínková M; Soukupová K
    Sb Lek; 1966 Jul; 68(7):216-22. PubMed ID: 5945311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.